Pawel Koziel
Overview
Explore the profile of Pawel Koziel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haberka M, Jankowski P, Kosior D, Szpakowicz M, Szostak-Janiak K, Koziel P, et al.
Arch Med Sci
. 2023 Apr;
19(2):305-312.
PMID: 37034537
Introduction: Cardiovascular disease is still a leading cause of death in Poland and across Europe. The aim of this study was to assess the attainment of the main treatment goals...
2.
Jankowski P, Koziel P, Pajak A
Cardiol J
. 2023 Jan;
30(1):150-152.
PMID: 36651571
No abstract available.
3.
Jankowski P, Koziel P, Bilo G, Pinkas J, Czarnecka D, Kawecka-Jaszcz K, et al.
Int J Hypertens
. 2022 Oct;
2022:2086515.
PMID: 36225816
Objective: To evaluate changes in blood pressure (BP) values in patients with established coronary artery disease (CAD) over 20 years (1997-2017). Materials And Methods: Consecutive patients aged <71 years and...
4.
Grodkiewicz M, Koziel P, Chmielewska I, Korbel M, Milanowski J
Curr Oncol
. 2022 Jul;
29(7):5077-5083.
PMID: 35877261
Idiopathic pulmonary fibrosis is a poorly prognosed form of progressive interstitial pneumonia. Patients with IPF have a significantly increased risk of developing lung cancer, which further worsens the course of...
5.
Setny M, Jankowski P, Kaminski K, Gasior Z, Haberka M, Czarnecka D, et al.
Pol Arch Intern Med
. 2021 Dec;
132(3).
PMID: 34935325
Introduction: Adherence to health‑promoting behaviors intended to mitigate modifiable risk factors plays an important role in secondary cardiovascular prevention. Objectives: We aimed to evaluate sex differences in the prevalence and...
6.
Jankowski P, Koziel P, Setny M, Paniczko M, Haberka M, Banach M, et al.
J Clin Med
. 2021 Aug;
10(16).
PMID: 34442006
Lipid-lowering in patients with coronary artery disease (CAD) is related to a lower risk of cardiovascular events. We evaluated factors related to the management of hypercholesterolemia in patients with established...
7.
Setny M, Jankowski P, Krzykwa A, Kaminski K, Gasior Z, Haberka M, et al.
J Clin Med
. 2021 Jul;
10(12).
PMID: 34208351
Cardiovascular diseases (CVDs) are the leading cause of death in Poland. Starting from 1992, a gradual decrease in mortality due to CVDs has been observed, which is less noticeable in...
8.
Drobek N, Sowa P, Jankowski P, Haberka M, Gasior Z, Kosior D, et al.
J Clin Med
. 2021 Jun;
10(9).
PMID: 34063006
Dysglycemia is a public health challenge for the coming decades, especially in patients with chronic coronary syndromes (CCS). We want to assess the prevalence of undiagnosed diabetes mellitus (DM) and...
9.
Peksa J, Jankowski P, Koziel P, Bogacki P, Gomula P, Mirek-Bryniarska E, et al.
Pol Arch Intern Med
. 2021 May;
131(7-8):673-678.
PMID: 34002973
Introduction: Patients with coronary artery disease (CAD) are at high risk of recurrent cardiovascular events, and risk factor control is crucial in this population. Objectives: The aim of the study...
10.
Jankowski P, Koziel P, Pajak A
Pol Arch Intern Med
. 2021 Mar;
131(3):316.
PMID: 33783178
No abstract available.